A phase II study assessing the feasibility and clinical efficacy of adaptive immunotherapy combination with VEGFR-TKI in patients with advanced renal cell carcinoma
Year: 2026
Type: article
Study design: Study Protocol
Source: Future Oncology
Authors: Firas Hatoum, Brandon Dyer, Jazlyn Heiligh, Trey Poehlman, Jingsong Zhang, Gigi Jameel, Sarah Mizelle, Aditi Patel, Amy Schneider, Adnan Fazili, Jeffrey S. Johnson, Justin W. Miller, Gabriel Roman Souza, Nadine Mahmoud, Keerthi Gullapalli, Youngchul Kim, Philippe E. Spiess, Robert Gatenby, Alexander R.A. Anderson, Jad Chahoud
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Moffitt Cancer Center
OpenAlex ID: W7212173517